RPE65 and Retinal dystrophy: Indeed, patients exhibiting mutations affecting LRAT and RPE65 are responsible for dramatic progressive ocular diseases called Leber congenital amaurosis and Retinitis pigmentosa, and these pathologies are characterized by several retinal dystrophies [24, 25].